DermaKnowlogy ApS: Financial statements 2022
CVR: 10055318
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
DermaKnowlogy ApS (CVR 10055318) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -920,155 and a net result of DKK -955,201 compared with DKK -713,508 the year before. Equity in the 2022 report amounted to DKK -4,518,179.
- Gross Profit
- DKK -920,155
- Profit/Loss
- DKK -955,201
- Equity
- DKK -4,518,179
- Total Assets
- DKK 1,699,696
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -920 t. | -955 t. | -4.5 mio. | - |
| 2021 | - | -654 t. | -714 t. | -3.6 mio. | - |
| 2020 | - | -559 t. | -641 t. | -2.8 mio. | - |
| 2019 | - | -1.7 mio. | -1.5 mio. | -2.2 mio. | - |
| 2018 | - | -538 t. | -475 t. | -717 t. | - |
Official annual report
Keep an eye on DermaKnowlogy ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
DermaKnowlogy ApS has published its annual report for 2021. Gross profit came to DKK -654,303, and the net result was DKK -713,508.
About DermaKnowlogy ApS
DermaKnowlogy ApS is a Danish company of the type Anpartsselskab based in Fårup, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SCAN CARE ApS and PBH 27.488 ApS. The management consists of Peter Bogh. The board consists of Mikkel Egelund Jensen (chair), Peter Bogh and Uffe Koppelhus. The company is owned by DERMA PHARM A/S and Uffe Koppelhus Holding ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -618,011 and a net result of DKK -607,032 compared with DKK -882,036 the year before. Equity in the 2025 report amounted to DKK -6,915,548.